Shanghai Labway Clinical Laboratory Co., Ltd.

Shenzhen Stock Exchange 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow Yield on January 27, 2025: 4.26%

Shanghai Labway Clinical Laboratory Co., Ltd. Free Cash Flow Yield is 4.26% on January 27, 2025, a 24.17% change year over year. Free cash flow yield compares the return from free cash flow to the market cap; higher yield suggests attractive investment.

Shanghai Labway Clinical Laboratory Co., Ltd. 52-week high Free Cash Flow Yield is 5.05% on July 24, 2024, which is 18.57% above the current Free Cash Flow Yield.
Shanghai Labway Clinical Laboratory Co., Ltd. 52-week low Free Cash Flow Yield is 2.68% on March 21, 2024, which is -37.00% below the current Free Cash Flow Yield.
Shanghai Labway Clinical Laboratory Co., Ltd. average Free Cash Flow Yield for the last 52 weeks is 3.94%.

Key data

Date	Free Cash Flow Yield	Market Value Added (MVA)	Price to Book Ratio (P/B)	Price to Earnings Ratio (P/E)

Shenzhen Stock Exchange: 301060.SZ

Shanghai Labway Clinical Laboratory Co., Ltd.

CEO	Mr. Weixiong Zeng
IPO Date	Sept. 13, 2021
Location	China
Headquarters	Building 1, Lane 268
Employees	1,487
Sector	Healthcare
Industries Biotechnology Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Hardware & Electronics Personal Care Professional Services Specialty Retail

Description

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

Key trends

Past 5 years